These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3728340)
1. Use of diuretic agents in obese or black patients with systemic hypertension. Messerli FH; Schmieder RE Am J Cardiol; 1986 Jul; 58(2):11A-14A. PubMed ID: 3728340 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy. Messerli FH J Clin Hypertens; 1985 Mar; 1(1):3-14. PubMed ID: 2425059 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiologic mechanisms in essential hypertension: a clue to the therapeutic approach. Messerli FH J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S875-9. PubMed ID: 6084143 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pathophysiology of essential hypertension: a clue to therapy. Messerli FH; Ventura HO Drugs; 1985; 30 Suppl 1():25-34. PubMed ID: 2994985 [TBL] [Abstract][Full Text] [Related]
6. Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). Palmieri V; de Simone G; Arnett DK; Bella JN; Kitzman DW; Oberman A; Hopkins PN; Province MA; Devereux RB Am J Cardiol; 2001 Nov; 88(10):1163-8. PubMed ID: 11703964 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of obesity and hypertension. Messerli FH Lancet; 1982 May; 1(8282):1165-8. PubMed ID: 6122945 [TBL] [Abstract][Full Text] [Related]
8. The problem of obesity and hypertension. Frohlich ED; Messerli FH; Reisin E; Dunn FG Hypertension; 1983; 5(5 Pt 2):III71-8. PubMed ID: 6629465 [TBL] [Abstract][Full Text] [Related]
9. Disparate cardiovascular effects of obesity and arterial hypertension. Messerli FH; Sundgaard-Riise K; Reisin E; Dreslinski G; Dunn FG; Frohlich E Am J Med; 1983 May; 74(5):808-12. PubMed ID: 6340494 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic role of extracellular fluid in hypertension. Tarazi RC Circ Res; 1976 Jun; 38(6 Suppl 2):73-83. PubMed ID: 773571 [TBL] [Abstract][Full Text] [Related]
12. Diuretics and the treatment of systemic hypertension. Aranda P; Lopez de Novales E Am J Cardiol; 1990 May; 65(17):72H-76H. PubMed ID: 2184656 [TBL] [Abstract][Full Text] [Related]
16. Does obesity influence early target organ damage in hypertensive patients? Schmieder RE; Messerli FH Circulation; 1993 May; 87(5):1482-8. PubMed ID: 8491003 [TBL] [Abstract][Full Text] [Related]
17. Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume state. Messerli FH; DeCarvalho JG; Christie B; Frohlich ED Am J Med; 1979 Jul; 67(1):27-31. PubMed ID: 463913 [TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of hypertension in obese subjects. Weidmann P; de Courten M; Boehlen L; Shaw S Drugs; 1993; 46 Suppl 2():197-208; discussion 208-9. PubMed ID: 7512475 [TBL] [Abstract][Full Text] [Related]
19. Obesity and hypertension. Hemodynamic aspects. Frohlich ED Ann Epidemiol; 1991 May; 1(4):287-93. PubMed ID: 1669510 [TBL] [Abstract][Full Text] [Related]